Increase/Decrease in Cash: The total change in cash for the company over the given period.
Dogwood Therapeutics, Inc (DWTX) had Increase/Decrease in Cash of $11.53M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-12.86M |
|
-- |
|
-- |
|
$12.23M |
|
$-12.23M |
|
$-0.12M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.23M |
|
$-12.16M |
|
1.03M |
|
1.03M |
|
$-12.52 |
|
$-12.52 |
|
| Balance Sheet Financials | |
$16.54M |
|
$0.02M |
|
$77.76M |
|
$94.31M |
|
$3.18M |
|
$15.38M |
|
$26.85M |
|
$30.03M |
|
$-10.12M |
|
$-13.24M |
|
$64.28M |
|
1.33M |
|
| Cash Flow Statement Financials | |
$-8.79M |
|
$3.76M |
|
$16.70M |
|
$3.32M |
|
$14.85M |
|
|
Increase/Decrease in Cash |
$11.53M |
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.21 |
|
-- |
|
-- |
|
0.19 |
|
0.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
121.99% |
|
93.27% |
|
-13.10% |
|
-15.50% |
|
$48.26 |
|
$-8.55 |
|
$-8.55 |
|